SAMHD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.443600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.324820E-01
Normal-vs-Stage2
1.326440E-01
Normal-vs-Stage3
2.757600E-02
Normal-vs-Stage4
3.624400E-01
Stage1-vs-Stage2
7.811400E-01
Stage1-vs-Stage3
4.093800E-01
Stage1-vs-Stage4
4.921200E-01
Stage2-vs-Stage3
1.516300E-02
Stage2-vs-Stage4
6.136800E-01
Stage3-vs-Stage4
1.191000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.132200E-02
Normal-vs-AfricanAmerican
7.944600E-01
Normal-vs-Asian
6.762000E-02
Caucasian-vs-AfricanAmerican
4.534000E-01
Caucasian-vs-Asian
4.815400E-01
AfricanAmerican-vs-Asian
3.535800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.952400E-02
Normal-vs-Female
1.646040E-01
Male-vs-Female
1.622970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.206600E-01
Normal-vs-Age(41-60Yrs)
2.471200E-01
Normal-vs-Age(61-80Yrs)
6.419600E-02
Normal-vs-Age(81-100Yrs)
1.394210E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.721400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.306600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.387600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.493380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.287600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.398000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.106090E-02
Normal-vs-Daily Drinker
1.081690E-03
Normal-vs-Weekly Drinker
8.949700E-02
Normal-vs-Occasional Drinker
3.645700E-02
Normal-vs-Social Drinker
3.298200E-01
Non Drinker-vs-Daily Drinker
4.660400E-01
Non Drinker-vs-Weekly Drinker
2.984000E-01
Non Drinker-vs-Occasional Drinker
8.265600E-01
Non Drinker-vs-Social Drinker
1.940010E-01
Daily Drinker-vs-Weekly Drinker
9.056200E-02
Daily Drinker-vs-Occasional Drinker
3.956400E-01
Daily Drinker-vs-Social Drinker
9.313500E-02
Weekly Drinker-vs-Occasional Drinker
4.800600E-01
Weekly Drinker-vs-Social Drinker
6.070800E-01
Occasional Drinker-vs-Social Drinker
2.584200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.724000E-01
Normal-vs-Grade 2
7.444600E-01
Normal-vs-Grade 3
7.809600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.368800E-01
Grade 1-vs-Grade 3
4.302800E-01
Grade 1-vs-Grade 4
9.724000E-01
Grade 2-vs-Grade 3
9.652400E-01
Grade 2-vs-Grade 4
7.444600E-01
Grade 3-vs-Grade 4
7.809600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.493700E-02
Normal-vs-NonDiabetic
5.288100E-02
Diabetic-vs-NonDiabetic
6.514000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.376200E-03
Normal-vs-NoPancreatitis
6.738000E-02
Pancreatitis-vs-NoPancreatitis
4.160000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.269500E-02
Normal-vs-N1
1.520400E-01
N0-vs-N1
8.901600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.578200E-02
Normal-vs-TP53-NonMutant
2.131600E-01
TP53-Mutant-vs-TP53-NonMutant
2.674000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
